Page results
-
The Ataxia Centre brings together a team of specialists, with expertise in the diagnosis, management and research of all forms of ataxia.
-
We offer comprehensive assessment, diagnostic services and investigation for all forms of the disease including neuropsychology, neurophysiology, imaging, genetic testing, and tissue diagnosis.
-
You can make a secure payment using our online portal. It is a convenient way to make a payment for a range of services and is available 24/7. When making a payment you will be directed a secure website hosted by The Access Group, a leading provider of business software. Payments can be made against an invoice raised by the Trust or for a range of other services which are set out when you access the portal.
-
The department specialises in the assessment and management of Complex Neuropsychiatric conditions occurring in the context of neurological disease.
-
Skeletal muscle channelopathies are rare neuromuscular diseases that cause symptoms of episodic muscle weakness/paralysis or cause difficulty in relaxing muscles (the muscle can feel stuck or cramped) once they are contracted.
-
This page is for patients who are about to start a course of radiotherapy to the prostate/prostate bed.
-
This booklet is designed for teenagers and young people. It explains what you can expect when you finish your treatment for Hodgkin lymphoma.
-
Information and advice for patients, relatives and carers about thoracic surgery.
-
The maternity team at UCLH will listen to your hopes and concerns and can suggest helpful and practical ideas to help you.
-
The service offers psychotherapeutic intervention for women receiving ante-natal and post-natal care at UCLH, their partners, and their children in the event of perinatal loss.
File results
-
FOI/2022/0209 - Patient tracking list or waiting lists
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust